QQQ $ 612.14 $ 1.56 (0.26 %)
DIA $ 470.45 $ 1.64 (0.35 %)
SPY $ 672.31 $ 2.95 (0.44 %)
TLT $ 89.45 $ -0.19 (-0.21 %)
GLD $ 367.77 $ 0.35 (0.1 %)
$ 0.6672
$ 0.68
$ 0.64 x 1,000
$ 0.70 x 1,000
$ 0.64 - $ 0.69
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 08-04-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 02-25-2025 12-31-2024 10-K
5 11-07-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 02-27-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-03-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-01-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-03-2022 12-31-2021 10-K
17 10-28-2021 09-30-2021 10-Q
18 08-04-2021 06-30-2021 10-Q
19 05-26-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 agilon-health-receives-notice-of-non-compliance-from-nyse-co-intends-to-seek-shareholder-approval-for-reverse-stock-split

To regain compliance agilon intends to seek shareholder approval for a reverse stock splitagilon health, inc. (the "Company...

 barclays-maintains-underweight-on-agilon-health-lowers-price-target-to-1

Barclays analyst Andrew Mok maintains Agilon Health (NYSE:AGL) with a Underweight and lowers the price target from $1.5 to $1.

 wells-fargo-maintains-overweight-on-agilon-health-lowers-price-target-to-1

Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and lowers the price target from $1....

 agilon-health-lowers-fy2025-sales-guidance-from-5850b-6025b-to-5810b-5830b-vs-5815b-est

Fiscal Year 2025 GuidanceGuidance reflects the full year impact of approximately $150 million from lower-than-expected risk adj...

 agilon-health-q3-eps-027-misses-016-estimate-sales-1435b-beat-1423b-estimate

Agilon Health (NYSE:AGL) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.16) ...

 wells-fargo-maintains-overweight-on-agilon-health-lowers-price-target-to-15

Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and lowers the price target from $5 ...

 bernstein-downgrades-agilon-health-to-market-perform-lowers-price-target-to-14

Bernstein analyst Lance Wilkes downgrades Agilon Health (NYSE:AGL) from Outperform to Market Perform and lowers the price ta...

 jefferies-maintains-hold-on-agilon-health-lowers-price-target-to-11

Jefferies analyst Jack Slevin maintains Agilon Health (NYSE:AGL) with a Hold and lowers the price target from $2.4 to $1.1.

 benchmark-maintains-buy-on-agilon-health-lowers-price-target-to-15

Benchmark analyst Bill Sutherland maintains Agilon Health (NYSE:AGL) with a Buy and lowers the price target from $4 to $1.5.

 barclays-maintains-underweight-on-agilon-health-lowers-price-target-to-15

Barclays analyst Andrew Mok maintains Agilon Health (NYSE:AGL) with a Underweight and lowers the price target from $3 to $1.5.

 citigroup-downgrades-agilon-health-to-neutral-lowers-price-target-to-1

Citigroup analyst Daniel Grosslight downgrades Agilon Health (NYSE:AGL) from Buy to Neutral and lowers the price target from...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION